FDA Drug recall D-1091-2017
0.9% Sodium Chloride Injection, USP in 1000 mL Single Dose Flexible Container, Hospira, Inc., Lake Forest, IL 60045 USA --- NDC# 0409-7983-…
- FDA Drug
- Class II
- terminated
- Published 2017-08-23
On 2017-08-23 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection, USP in 1000 mL Single Dose Flexible Container, Hospira, Inc., Lake Forest, IL 60045 USA --- NDC# 0409-7983-… by Icu Medical, citing presence of Particulate Matter; stainless steel.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1091-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-07-26 |
| Published | 2017-08-23 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Icu Medical |
| Distribution | US |
Product
0.9% Sodium Chloride Injection, USP in 1000 mL Single Dose Flexible Container, Hospira, Inc., Lake Forest, IL 60045 USA --- NDC# 0409-7983-09
Reason
Presence of Particulate Matter; stainless steel
Identifiers
| code_info | Lot: 61-841-FW Exp. 01/01/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1091-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.